Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

By Shariat S.F.   Andrews B.   Kattan M.W.   Kim J.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 1008-1015

Elsevier

Access to resources Recommend Favorite

Serum Interleukin-11 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer

By Furuya Yuzo   Nishio Remon   Junicho Akira   Nagakawa Osamu   Fuse Hideki  

International Urology and Nephrology, Vol. 37, Iss. 1, 2005-03 ,pp. : 69-71

Springer Publishing Company

Access to resources Recommend Favorite

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer

By Blana Andreas   Rogenhofer Sebastian   Ganzer Roman   Wild Peter   Wieland Wolf   Walter Bernhard  

World Journal of Urology, Vol. 24, Iss. 5, 2006-11 ,pp. : 585-590

Springer Publishing Company

Access to resources Recommend Favorite

Laparoscopic extended pelvic lymphadenectomy for staging can be performed with limited morbidity and short hospital stay in patients with prostate cancer

By Liedberg Fredrik   Kjölhede Henrik   Sundqvist Pernilla  

Scandinavian Journal of Urology and Nephrology, Vol. 46, Iss. 5, 2012-10 ,pp. : 332-336

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-6 Upregulates GP96 Expression in Breast Cancer

By Haverty A.A.   Harmey J.H.   Redmond H.P.   Bouchier-Hayes D.J.  

Journal of Surgical Research, Vol. 69, Iss. 1, 1997-04 ,pp. : 145-149

Academic Press

Access to resources Recommend Favorite